Marvel Biosciences (TSXV:MRVL) Buyback Yield % : 0.00 (As of Apr. 18, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Marvel Biosciences Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Marvel Biosciences's current buyback yield was 0.00%.

Marvel Biosciences Buyback Yield % Historical Data

The historical data trend for Marvel Biosciences's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences Buyback Yield % Chart

Marvel Biosciences Annual Data

Trend

Jul20

Jul21

Jul22

Jul23

Jul24

Buyback Yield %

-41.42

-13.32

-8.48

-9.30

Marvel Biosciences Quarterly Data
	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Buyback Yield %	Get a 7-Day Free Trial														-	-	-9.30	-	-

Competitive Comparison of Marvel Biosciences's Buyback Yield %

For the Biotechnology subindustry, Marvel Biosciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marvel Biosciences's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marvel Biosciences's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Marvel Biosciences's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Marvel Biosciences Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Marvel Biosciences's Buyback Yield for the fiscal year that ended in Jul. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0.5)	/	5.37432
	=	-9.30%

Marvel Biosciences's annualized Buyback Yield for the quarter that ended in Jan. 2025 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	0)		/	6.94462
	=	0.00%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Marvel Biosciences Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Marvel Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (TSXV:MRVL) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

MBCOF:USA

Address

505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2

Website

https://www.marvelbiotechnology.com

Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.

Executives